Multiple Sclerosis Treatment in Turkey

Understanding Multiple Sclerosis and Its Common Symptoms

Multiple sclerosis (MS) is a chronic autoimmune condition affecting the central nervous system. In patients with MS, the immune system mistakenly attacks the protective myelin sheath surrounding nerve fibres in the brain and spinal cord. This disruption leads to communication signals between the brain and the rest of the body becoming slowed, distorted, or blocked completely. Over time, the disease can cause permanent damage or deterioration of the nerves themselves.

The clinical presentation of MS varies significantly depending on the location and severity of nerve damage. Initial symptoms often appear in adults between the ages of 20 and 40. Patients typically consult a medical professional after experiencing one or more of the following common signs:

• Sensory changes: Numbness, tingling, or a severe burning sensation in the limbs, trunk, or face.
• Visual disturbances: Optic neuritis, which causes sudden partial or complete loss of vision (usually in one eye), eye pain during movement, or double vision.
• Motor weakness: Muscle stiffness, spasms, or weakness in the legs and arms, making walking or lifting objects difficult.
• Coordination and balance problems: Unsteadiness, dizziness, or difficulty maintaining balance (ataxia).
• Fatigue and cognitive changes: Overwhelming physical exhaustion unrelated to exertion, alongside occasional brain fog or memory issues.

How Multiple Sclerosis Is Diagnosed in Turkey

Diagnosing MS requires careful exclusion of other neurological disorders that produce similar symptoms. When evaluating international patients, specialist centres in Turkey follow internationally recognised diagnostic criteria, such as the Revised McDonald Criteria. International patients visiting a neurological clinic should bring their complete medical history, previous scan reports, and a timeline of symptom flare-ups.

A thorough diagnostic assessment overseen by a neurology team typically involves several precise investigations:

• High-Field Magnetic Resonance Imaging (MRI): Brain and spinal cord scans using contrast agents to detect active or old areas of demyelination (lesions).
• Lumbar Puncture (Spinal Tap): Analysis of cerebrospinal fluid to check for elevated levels of IgG antibodies and specific proteins called oligoclonal bands, which indicate an active immune response in the central nervous system.
• Evoked Potential Tests: Electrical response tests that measure how quickly and accurately nerve pathways send signals in response to visual or electrical stimuli.
• Blood Analysis: Extensive laboratory work to rule out infectious diseases, vitamin deficiencies, and autoimmune conditions like neuromyelitis optica.

Treatment Options and Clinical Approaches

While there is currently no cure for multiple sclerosis, modern therapeutic strategies focus on reducing the frequency and severity of relapses, managing ongoing symptoms, and slowing disease progression. Treatment decisions are tailored to the patient's specific MS subtype (such as Relapsing-Remitting MS or Secondary Progressive MS) and are made after a thorough evaluation by a neurologist.

Planning Your Medical Travel to Turkey

Travelling abroad for MS management requires structured planning. Neurological care often intersects with surgical evaluation, such as Neurosurgery consultations, to exclude structural spinal compression before finalizing a treatment pathway. Before booking travel, patients should upload all recent MRI digital files (DICOM format) and clinical notes for an initial remote file review by the attending medical team.

Patients should plan to stay in Turkey for 7 to 14 days to allow adequate time for comprehensive clinical testing, specialist appointments, and immediate monitoring if new treatments or infusions are initiated. Before returning home, the international patient department will provide a detailed summary of all diagnostic results and treatment protocols, allowing your primary neurologist at home to take over ongoing care seamlessly.

When Travel Is Not Advisable and Warning Signs

Long-distance travel places physical stress on the body and is not appropriate for every patient with MS. Travelling for international care should be postponed during an acute, severe relapse, or if mobility is so impaired that sitting for long flights poses high risks of deep vein thrombosis or severe fatigue.

You should seek immediate emergency local care rather than undertaking international travel if you experience acute red-flag symptoms, including sudden severe shortness of breath, rapidly worsening limb paralysis, acute loss of bowel or bladder control, or sudden severe confusion and fever.